Merck to Share Covid Pill Formula With Poor Countries
Merck, the American pharmaceutical company, has signed a royalty-free license waiver for their oral antiviral COVID drug molnupiravir. This will...
Read moreDetailsMerck, the American pharmaceutical company, has signed a royalty-free license waiver for their oral antiviral COVID drug molnupiravir. This will...
Read moreDetailsEmpowerFULL is a social impact startup that aims to help victims of modern slavery. Having just launched their first pilot...
Read moreDetailsNFTs are booming and becoming an increasingly popular way to buy and sell digital artworks, though they can also be...
Read moreDetailsIn October 2020, Marijam Bieber launched Nudo, a line of natural body care accessories that are 100 percent plastic free,...
Read moreDetailsTwelve years ago, in an effort to curb rising emissions, high income countries promised to provide $100 billion in climate...
Read moreDetails
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.